Search

Your search keyword '"Prashant Mehta"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Prashant Mehta" Remove constraint Author: "Prashant Mehta"
107 results on '"Prashant Mehta"'

Search Results

1. Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India

2. Epidemiology and survival analysis of head and neck cancer: Results from comprehensive care center in North India

3. Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India

4. Real-World Breast Cancer Patient Follow-Up Practices by Medical Oncologists in India—A Survey Report

5. South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients

6. Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

8. Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)

9. Oncotype DX: Where Does It Stand in India?

15. Real World Data on Unique Challenges and Outcomes of Older Patients with AML from Resource Limited Settings: Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC)

16. Pembrolizumab weight based dosing – A call for policy change

17. Work alienation as a mediator between work from home-related isolation, loss of task identity and job insecurity amid the COVID-19 pandemic

18. Consumers’ usage of food delivery app: a theory of consumption values

19. The Impact of Website Design on Online Customer Buying Satisfaction and Loyalty to E-Tailers

21. Characteristicsoutcomes of cancer patients with COVID-19: A multicentre retrospective study from India

23. South Asian Declaration—Consensus Guidelines for COVID-19 Vaccination in Cancer Patients

24. Teachers’ readiness to adopt online teaching amid COVID-19 lockdown and perceived stress: pain or panacea?

26. Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience

27. Induction Related Mortality Score in Acute Myeloid Leukemia: Prospective Validation Study (pRISM) of the Hematology Cancer Consortium (HCC)

28. COVID-19 and E-Learning Adoption in Higher Education: A Multi-Group Analysis and Recommendation

29. Robust Protective Effect of COVID-19 Vaccination in India—Results of Survey in the Midst of Pandemic’s Second Wave

30. Midst of COVID-19 Crisis – Lookout for One Another to Practice Humanity!

31. Clinical Trials Facing 'Serious Adverse Events' during the Ongoing COVID-19 Pandemic

32. Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2

33. Cancer Surgery in Challenging Time of COVID-19 Pandemic – A Pragmatic Approach

34. Colorectal Cancer Chemotherapy during COVID-19 Pandemic

35. 'Serious Adverse Events' Faced by Clinical Trials: Impact of the COVID-19 Pandemic

36. How We Treat lung Cancer during SARS-Cov-2 (COVID-19) Pandemic in India?

38. PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review

39. Profile of Mucormycosis Cases from a Network of Hospitals in North India Amidst COVID-19 Pandemic

40. How I Treat Epithelial Ovarian Cancer during COVID-19 Pandemic

41. Gallbladder Cancer: Adjuvant and Palliative Treatment during Covid-19 Pandemic in India

42. Systemic Treatment of Gastroesophageal Cancer during SARS-CoV2

43. Management of Head-and-Neck Cancer during COVID-19 Crisis: A Medical Oncology Perspective

44. Breast Cancer Treatment during the COVID-19 Pandemic

45. Conflict of interest disclosure and interpretation - rest assured the medical professional in the audience is perceptive, alert and smart

46. Factors associated with recurrence in oral cavity squamous cell carcinoma: A real-world experience from an Indian comprehensive cancer center

47. Response assessment and toxicity in patients treated with immune checkpoint inhibitors in solid tumors : A comprehensive cancer care center experience from India

48. PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review

49. Work from home-Work engagement amid COVID-19 lockdown and employee happiness

50. Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)

Catalog

Books, media, physical & digital resources